Watertime, Author at PsyNews.com

Home Authors Posts by Watertime

209 POSTS 0 COMMENTS

Pα+ Psychedelic Bulletin #198: New Data Offers Look at Spravato’s Long-Term...

Psychedelics in Japan: Dr. Hiroyuki Uchida on Studies, Stigma, and the...

Paul Gillis-Smith – Psychedelics, Religion & Lisa Bieberman

FDA’s Makary Hints at Faster Reviews for Psychedelic Therapies

Pα+ Psychedelic Bulletin #197: Portuguese Health-Related Professions Unite on Psychedelics; Shrooms,...

The Interdisciplinary Annotated Psychedelic Research Bibliography of 2024

Reflections on the 2025 Federal Policy Summit on Psychedelic Medicine

Spring 2025 Psychedelic Policy Update: Bills Hang in the Balance as...

Dr Simon Ruffell – Other Ways of Knowing

Dispatch from Breaking Convention 2025: Key Takeaways from Europe’s Largest Psychedelic...

1 234...21 Page 3 of 21

Pα+ Psychedelic Bulletin #201: Dispatches from Prague and London; Texas Becomes...

May 2025 Psychedelic Patent Update: Gilgamesh Broadens Moat Around Lead Candidate...

Win 10 Groundbreaking Psychedelic Books – Our Giveaway with Inner Traditions!

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Watertime